Categories

Advocacy

Biomarkers

Clinical Trials

CRC Awareness

Health Equity

Members Monthly Meetings

Member Spotlight

Mentorship

News

Patient Stories

Policy

Research

Policy

GCCA is supporting colorectal cancer policy change around the world.

No items found.

What the New WHO Global Cancer Report Means for the Colorectal Cancer Community

New report highlights major gaps in CRC screening, care, and outcomes.

Most Favored Nation (MFN) Drug Pricing Could Cost Cancer Patients Future Breakthroughs

GCCA CEO speaks on the risks of MFN policy.

From Chicago to Seville: A Busy Start to the Second Half

GCCA President shares highlights from ASCO and PEOF.

WHO Resolution Signals a Global Commitment to Precision Medicine Equity

A new WHO resolution highlights the growing global commitment to equitable access to precision medicine and biomarker testing.

Strengthening Global Collaboration to Improve Cancer Care

Reflections from the Global Cancer Coalitions Network Annual Meeting 2026

April Member Meeting

A recap of April's member meeting with speakers Andrew Spiegel, Esq. and Dr. Deepak Govil.

Advancing Colorectal Cancer Prevention and Precision Medicine in Mexico

Global Colon Cancer Association, FUTEJE, and From Testing to Targeted Treatment Launch New Collaboration During Colorectal Cancer Awareness Month

Policy News: U.S. Federal Budget Passage

Learn about the bill's impact on CRC patients.

The 'Count Us In' Pact

Read about the motivation and meaning behind the 2025 Global CRC Congress and the pledge to make sure every person with cancer is counted.

July Members Meeting

A recap of the July monthly member meeting.

DPD Deficiency and Colorectal Cancer Treatment

Learn about DPD deficiency and its relevance in cancer treatment.

Tariffs Threaten Pharmaceutical Access and Innovation

Learn about the implications of potential pharmaceutical tariffs.

Immunotherapy Policy Change in Taiwan

Learn about the Taiwan Young Patient Association's work on immunotherapy policy.

GCCA on "Most Favored Nation" Drug Pricing Executive Order

Read GCCA's statement on Trump's "most favored nation" drug pricing policy.

Webinar - Transforming Policy

Transforming Policy webinars support patient advocacy groups to change colorectal cancer policy.